Drägerwerk AG & Co. KGaA (DRW3) Stock Price, News & Analysis

Company Overview

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.

Key Stats

• Today's Range: €87.80 to €90.20
• 50-Day Range: €81.10 to €99.40
• 52-Week Range: €43.20 to €56.20
• Volume: 10,150 shs
• Average Volume: 33,804 shs
• Market Capitalization: €1.57 billion
• P/E Ratio: 14.88
• Dividend Yield: 2.53%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ETR
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ETR:DRW3
• CIK: N/A
• Web: www.draeger.com
• Phone: +49-451-8820
• Fax: N/A
• Employees: 16,476
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): €6.04
• Trailing P/E Ratio: 14.88
• Forward P/E Ratio: 20.20
• P/E Growth: 1.24
• Net Income: €103.84 million
• Net Margins: 4.36%
• Pretax Margin: N/A
• Return on Equity: 9.79%
• Return on Assets: 3.63%

Debt

• Debt-to-Equity Ratio: 13.64
• Current Ratio: 2.07
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: €3.46 billion
• Price / Sales: 0.45
• Cash Flow: €25.07 per share
• Price / Cash Flow: 3.59
• Book Value: €88.29 per share
• Price / Book: 1.02

Miscellaneous

• Outstanding Shares: 17,430,281
• Free Float: N/A
• Market Cap: €1.57 billion
• Optionable: Not Optionable
• Beta: 0.56